Skip to main content
Livermore
Livermore
ZHEN

Drugs Made In America Acquisition Corp.

DMAAR
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002028614

No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.27M in total; no superinvestor holds it.

Other share classesDMAADMAAU

Q2 2025 vs. Q1 2025

How the institutions holding Drugs Made In America Acquisition Corp. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of DMAAR: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders19124+6
Shares14.2M209.9K18.3M+4.34M (+31.1%)
Value$1.72M$21.0K$2.22M+$515.2K (+30.3%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Drugs Made In America Acquisition Corp. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to DMAAR in Q2 2025
InstitutionSharesValue% of portfolio
Toronto Dominion Bank1,945,600$233.9K0.00%
Heights Capital Management, Inc633,816$79.2K0.02%
Boothbay Fund Management, LLC570,000$68.5K0.00%
Westchester Capital Management, LLC500,000$62.5K0.00%
Mizuho Securities USA LLC209,897$21.0K0.00%
Verition Fund Management LLC100,000$12.5K0.00%
Bulldog Investors, LLP72,964$8.77K0.00%

Sold out (1)

Institutions that held Drugs Made In America Acquisition Corp. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of DMAAR in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Warberg Asset Management LLC18,443$2.40K

Not filed for Q2 2025 yet (1)

Institutions that held Drugs Made In America Acquisition Corp. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DMAAR in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Mizuho Securities USA LLC209,897$21.0K